small cell lung cancer
FDA Approves Imfinzi for Limited-Stage Small Cell Lung Cancer
The FDA approved Imfinzi for adults with limited-stage small cell lung cancer whose disease has not progressed ...
DECEMBER 6, 2024
FDA Approves Tecentriq Hybreza for Subcutaneous Injection for All Adult Indications of IV Tecentriq
The FDA has approved Tecentriq Hybreza for subcutaneous injection as the intravenous formulation of Tecentriq.
SEPTEMBER 16, 2024
FDA Grants Accelerated Approval to Imdelltra for Extensive-Stage Small Cell Lung Cancer
The FDA has granted accelerated approval to Imdelltra for extensive-stage small cell lung cancer with disease ...
MAY 17, 2024
Study Defines SCLC Subtypes With Distinct Therapeutic Vulnerabilities
Countering the one-size-fits-all treatment for small-cell lung cancer, investigators classified the malignancy into ...
FEBRUARY 2, 2021
Imfinzi Approved for First-Line Treatment of Extensive-Stage SCLC
The FDA approved durvalumab (Imfinzi, AstraZeneca) in combination with etoposide and either carboplatin or ...
APRIL 6, 2020
Keytruda Gains Approval for Treatment of SCLC
The FDA granted accelerated approval to pembrolizumab (Keytruda, Merck) for the treatment of patients who have ...
JUNE 20, 2019
FDA Approves Opdivo as Third-Line Rx for SCLC
The FDA granted accelerated approval to nivolumab (Opdivo, Bristol-Myers Squibb) for the treatment of patients with ...
AUGUST 21, 2018
Statins Do Not Benefit Patients With Lung Cancer
It was initially thought that lowering cholesterol levels could impair the development and growth of cancer cells, ...
FEBRUARY 28, 2017
